BioLife Solutions, Inc. Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
BioLife Solutions, Inc. (BLFS) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of -$42.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2026-08-06
- BioLife Solutions, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2026-03-31 was -$500.00K.
- BioLife Solutions, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2025-03-31 was -$500.00K, a 183.33% decline year-over-year.
- BioLife Solutions, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2024-03-31 was $600.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 9 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | -$42.40M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$500.00K 10-Q · filed 2026-05-07 | |||
| 2025-09-30 | -$700.00K 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$600.00K 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | -$500.00K 10-Q · filed 2025-05-08 | |||
| 2024-09-30 | $1.20M 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $1.20M 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | $600.00K 10-Q · filed 2024-05-10 | |||
| 2023-09-30 | -$1.20M 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $400.00K 10-Q · filed 2023-08-09 | |||
| 2022-09-30 | $505.00K 10-Q · filed 2023-05-11 | $510.00K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |